Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) CEO Ajan Reginald speaks to Proactive about his plans for the main-market listed biotech company over the year to come. He also gives a fresh update on what Roquefort Therapeutics achieved during the final quarter of 2022 and reveals an important new hire.
Contact Details
Proactive
Proactive UK Ltd
+44 20 7989 0813